Associations of ADH1B and ALDH2 genotypes and alcohol flushing with drinking history, withdrawal symptoms, and ICD-10 criteria in Japanese alcohol-dependent men.

OBJECTIVES

Given the high prevalence of fast-metabolizing alcohol dehydrogenase-1B2 (ADH1B2 ) and inactive aldehyde dehydrogenase-22 (ALDH22 ) alleles in East Asians, we evaluated how the ADH1B / ALDH2 genotypes and alcohol flushing might affect the development of alcohol dependence (AD).

METHODS

We evaluated how the ADH1B / ALDH2 genotypes and self-reported alcohol flushing affected history of drinking events and withdrawal symptoms and ICD-10 criteria in 4116 Japanese AD men.

RESULTS

The ADH1B1/1 group and ALDH21/1 group were 1-5 years younger than the ADH1B2 (+) and ALDH21/2 groups, respectively, for all of the ages at onset of habitual drinking, blackouts, daytime drinking, uncontrolled drinking, withdrawal symptoms, and first treatment for AD, and the current age. Blackouts were more common in the ADH1B1/1 group and ALDH21/1 group. Daytime drinking, uncontrolled drinking, and withdrawal symptoms, such as hand tremor, sweating, convulsions, and delirium tremens/hallucinations were more common in the ADH1B1/1 group. The ADH1B1/1 was positively associated with the ICD-10 criteria for 'tolerance' and 'withdrawal symptoms'. The ADH1B1/1 group and ALDH21/2 group had a larger ICD-10 score. Never flushing was reported by 91.7% and 35.2% of the ALDH21/1 and ALDH21/*2 carriers, respectively. After a 1-2-year delay in the onset of habitual drinking in the former-/current-flushing group, no differences in the ages of the aforementioned drinking milestones were found according to the flushing status.

CONCLUSION

The ADH1B*1/1 and ALDH21/1 accelerated the development of drinking events and withdrawal symptoms in Japanese AD patients. ICD-10 score was larger in the ADH1B1/1 group and ALDH21/*2 group. The effects of alcohol flushing on drinking events were limited.